Clinical Trials Browser

Not yet recruiting × Adenocarcinoma of Lung × aflutinib × Clear all

NCT06483672 2024-07-03

LungBrain001

Phase 2 Not yet recruiting

Adenocarcinoma of Lung, Brain Neoplasms

NCT04965831 2021-07-16

Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT)

Phase 2 Not yet recruiting

Adenocarcinoma of Lung